Suppr超能文献

[术前放疗后保守性手术治疗乳腺癌。适应证与结果]

[Conservative surgery after preoperative radiotherapy in the treatment of breast cancer. Indications and results].

作者信息

Durand J C, Solalinde V, Mathieu G, Salmon R J, Bataini P, Vilcoq J R, Hamelin J P, Pilleron J P

机构信息

Service de Chirurgie générale, Institut Curie, Paris, France.

出版信息

Bull Cancer. 1987;74(6):641-6.

PMID:3435789
Abstract

From 1969 to 1983, 122 patients with unifocal breast cancer, equal or more than 3 centimeters in diameter, NON1a or N1b, were treated at the Institut Curie with conservative surgery after pre-operative external irradiation. Among them were 68% T2NON1a, and 26% N1b (with 21% T2N1b); 80% of the tumors were located in the upper part of the breast. Initial radiotherapy with a moderate dose (50 to 55 Gy for the breast and the lower axillary area) was followed 6 weeks later by a lumpectomy either alone (42 cases) or associated to an axillary node resection (80 cases). Five year survival rate with non evident disease T2NON1a cases is 79%, similar to the radical surgery rate in this group. We noted 8% local recurrences with no axillary recurrences. Post operative courses were a little more troubled than with initial lumpectomy. We noted 8% of upper limb oedema, only in patients who received both radiotherapy and surgery in the axilla. Cosmetic results are good in 65% of the cases, while they are good in 80% for initial lumpectomy. So this therapeutic method gives satisfactory results, but we need more cases with a longer follow-up to draw definitive conclusions.

摘要

1969年至1983年期间,居里研究所对122例直径等于或大于3厘米的单灶性乳腺癌患者(NON1a或N1b)在术前进行外照射后采用保乳手术治疗。其中68%为T2NON1a,26%为N1b(21%为T2N1b);80%的肿瘤位于乳房上部。首先进行中等剂量的初始放疗(乳房及腋下低位区域为50至55 Gy),6周后进行单纯肿块切除术(42例)或联合腋窝淋巴结切除术(80例)。T2NON1a病例无明显疾病的五年生存率为79%,与该组根治性手术率相似。我们发现局部复发率为8%,无腋窝复发。术后病程比初次肿块切除术后稍复杂。我们发现8%的患者出现上肢水肿,仅见于腋窝接受放疗和手术的患者。65%的病例美容效果良好,而初次肿块切除术的美容效果良好率为80%。因此,这种治疗方法取得了令人满意的结果,但我们需要更多病例并进行更长时间的随访才能得出明确结论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验